OMB Completes Review Of FDA’s Cannabis Research Draft Guide

By Beth Wang / July 8, 2020 at 4:58 PM
The White House Office of Management and Budget last week completed its review of FDA’s draft guidance on quality considerations for clinical research on cannabis. Once issued, the draft will be the first agency guidance focused specifically on cannabis, coming as House appropriators again propose funding the FDA’s long-awaited CBD regulatory framework . OMB completed its review of the draft document Thursday (July 2), just slightly more than a month after FDA sent the draft for review . FDA has...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.